Expiration date: 01/2025
Ajisept® with pineapple flavor
Ajisept® taste of honey
Ajisept® with raspberry flavor
Ajisept® with banana taste
Pastilles for resorption antiseptic
One pastille for resorption contains:
active ingredients: amylmetacresol........................0, 60 mg.,
alcohol 2, 4-dichlorobenzyl .......1, 20 mg
excipients: sugar 1560, 0 mg, liquid glucose 1010, 0 mg, citric acid anhydrous 24, 0 mg, menthol 5, 22 mg, purified water-sufficient
pineapple flavor-pineapple flavor 0, 0132 ml, quinoline dye yellow WS 0, 181 mg
orange flavor-orange flavor 0, 0108 ml, yellow sunset dye 0, 24 mg
banana flavor - banana flavor 12, 0 mg, quinoline dye yellow WS 0, 1944 mg
lemon flavor-lemon flavor 0, 0108 ml, yellow sunset dye 0, 012 mg, quinoline yellow dye WS 0, 24 mg
raspberry flavored-raspberry flavor 13, 2 mg, carmoisin 19, 44 mg
honey flavor-honey flavor 0, 0096 g, quinoline yellow dye WS 0, 168 mg, caramel color 0, 72 mg.
Yellow round biconvex lozenge with the taste of pineapple and sour taste.
Orange round biconvex lozenges with orange flavor and sour taste.
Yellow round biconvex lozenge with the taste of banana and sour taste.
Yellow round biconvex lozenges with lemon flavor and sour taste.
Red round biconvex lozenges with raspberry flavor and sour taste.
Taste of honey
Brownish-yellow, round biconvex lozenge with the taste of honey and a sour taste.
Drugs for the treatment of throat diseases. Antiseptics. Other drugs.
Combined antiseptic preparation with anti-inflammatory effect for topical use in the mouth and pharynx. It has antimicrobial effect. Active against a wide range of gram-positive and gram-negative microorganisms.
Indications for use
- infectious and inflammatory diseases of the oral cavity and pharynx
Dosage and administration
Adults: 1 lozenge every 2 hours. The maximum daily dose of 8 lozenges.
Pastilles resolves to dissolve.
- allergic reaction
- hypersensitivity to the drug components
- children under 18 years
Clinically significant drug interactions Er® with drugs of other groups.
When taking the drug to patients with diabetes, it should be borne in mind that each pastille contains 1.56 mg of sugar.
Pregnancy and lactation:
The use of Agisept® during pregnancy and lactation is possible after assessing the benefit/risk ratio for both the mother and the fetus or child.
Features of the effect of the drug on the ability to drive a vehicle or potentially dangerous mechanisms
Agisept® does not affect the ability to drive vehicles and other mechanisms.
Due to low systemic absorption, overdose is unlikely.
Symptoms: discomfort from the gastrointestinal tract.
Treatment: symptomatic therapy.
Shape of release and packing
6 lozenges in a contour-free packaging made of aluminum foil.
4 contour packaging with the instruction on medical application in the cardboard pack.
Store in a dry, dark place at a temperature not exceeding 30°C.
Keep out of reach of children!
Do not use after the expiry date indicated on the package.